Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Pharmacogenomics and its application in individualized use of antitumor agents in Chinese cancer patients

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Poster
  • By: CAI, Weimin (Fudan University, School of Pharmacy, Shanghai, China)
  • Co-author(s): Zhang, Yuxin (Fudan University, School of Pharmacy, Shanghai, China)
    Xu, Jialin (Fudan University, School of Pharmacy, Shanghai, China)
    Shao, Tengfei (Fudan University, School of Pharmacy, Shanghai, China)
  • Abstract:

    AIM: To explore recent development of pharmacogenomics and its application in individualized use of  antitumor agents in Chinese  cancer patients. METHOD: Mechanism of action of clinically common  antitumor agents was compared. Concept of pharmacogenomics was introduced, with an emphases on research cases of tamoxifen,irinotecan and..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses